| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 2 | |
| #2 | United States | 2 | |
| #3 | Brazil | 1 | |
| #4 | Canada | 1 | |
| #5 | China | 1 | |
| #6 | EPO (European Patent Office) | 1 | |
| #7 | Spain | 1 | |
| #8 | Hong Kong | 1 | |
| #9 | Russian Federation | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Medical technology | |
| #3 | Measurement | |
| #4 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Object sterilising | |
| #4 | Unspecified technologies | |
| #5 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Isern Amengual Bernat | 8 |
| #2 | Perello Bestard Joan | 7 |
| #3 | Salcedo Roca Carolina | 5 |
| #4 | Joubert Pieter H | 5 |
| #5 | Ferrer Reynes Miquel David | 4 |
| #6 | Tur Espinosa Fernando | 3 |
| #7 | Martín Becerra Eva | 2 |
| #8 | Monjo Cabrer Marta | 2 |
| #9 | Bernat Isern Amengual | 1 |
| #10 | Perelló Bestard Joan | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2019167702A1 | Use of derivatives containing c-o-p bonds in patients with kidney failure | |
| ES2754280A1 | Dosage guidelines for IP and IP analogues for the treatment of ectopic calcifications (Machine-translation by Google Translate, not legally binding) | |
| AU2014229971A1 | Use of derivatives with C-O-P bonds in patients with renal failure | |
| US2015004208A1 | Biocompatible implant | |
| EP2764360A1 | Method for the direct detection and/or quantification of at least one compound with a molecular weight of at least 200 |